Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Crit Care Med ; 29(12): 2281-6, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11801825

ABSTRACT

BACKGROUND: Previously, mainly retrospective and a few important prospective studies postulated the role of sepsis or systemic inflammatory response syndrome (SIRS), multiple organ failure, and the use of medication as causative factors for the development of critical illness polyneuropathy and myopathy (CIPNM). This study aimed to identify the risk factors in the development of CIPNM. METHODS: Prospectively, we studied 98 patients who were on artificial respirators for the development of CIPNM. The Acute Physiology and Chronic Health Evaluation (APACHE) III score, presence of SIRS, and sepsis severity score at entry; the dosage of midazolam, vecuronium, and steroids at entry and day 7 of artificial respiration; and the use of aminoglycosides at entry were related with time to CIPNM or time of last follow-up. The Kaplan-Meier method and log-rank test were used. RESULTS: Thirty-two patients (33%) developed CIPNM. After multivariate analysis, it was found that the APACHE III score and the presence of SIRS were significantly related with risk for the development of CIPNM. No significant relation was found for the use of midazolam, vecuronium, or steroids. Based on a risk index from a Cox regression model with APACHE III score and presence of SIRS as outcomes, three groups could be constructed with low-, medium-, and high-risk patients for the development of CIPNM. CONCLUSIONS: The APACHE III score, a quantitative index of disease severity based on clinical and laboratory physiologic data, is a valuable predictor for the development of CIPNM in patients in the intensive care unit. Together with the presence of SIRS, it can be used to estimate the risk of developing CIPNM for patients on artificial respirators.


Subject(s)
Muscular Diseases/etiology , Polyneuropathies/etiology , APACHE , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Incidence , Intensive Care Units , Male , Middle Aged , Multivariate Analysis , Muscular Diseases/epidemiology , Muscular Diseases/prevention & control , Netherlands/epidemiology , Polyneuropathies/epidemiology , Polyneuropathies/prevention & control , Proportional Hazards Models , Prospective Studies , Risk Factors , Systemic Inflammatory Response Syndrome/complications
2.
Ned Tijdschr Geneeskd ; 144(30): 1428-32, 2000 Jul 22.
Article in Dutch | MEDLINE | ID: mdl-10932694

ABSTRACT

Critical-illness polyneuropathy and myopathy (CIPNM) can be considered a part of the syndrome of multiple organ dysfunction. CIPNM is the commonest cause of muscle weakness acquired in the intensive care unit. Its incidence is 35-80% during prolonged mechanical ventilation. For a (differential) diagnosis, electrophysiological investigations are usually necessary, and sometimes a muscle biopsy. CIPNM may be induced by triggering of the immune response leading to increased vascular permeability with tissue invasion of inflammatory cells and local damage. There is a relation between myopathy and medication, notably corticosteroids. Clinical improvement usually follows when the CIPNM patient survives the underlying disease, but weaning from artificial ventilation is often difficult, and rehabilitation prolonged.


Subject(s)
Critical Care/methods , Multiple Organ Failure/complications , Muscular Diseases/etiology , Polyneuropathies/etiology , Respiration, Artificial/adverse effects , Critical Illness , Humans , Multiple Organ Failure/physiopathology , Treatment Outcome , Ventilator Weaning
3.
J Neuroimmunol ; 106(1-2): 206-13, 2000 Jul 01.
Article in English | MEDLINE | ID: mdl-10814799

ABSTRACT

In a longitudinal prospective study a muscle biopsy was taken from 30/32 (33%) of the 98 patients who developed critical illness polyneuropathy and myopathy (CIPNM). Neuropathic changes were found in 37%, myopathic in 40%, and a combination in 23% of the biopsies. The immunohistopathology showed macrophages and Th-cells in 40% and 60% of the muscle biopsies respectively. Small mainly perivascular infiltrates contained macrophages and Th-cells. ICAM-1, VCAM and MAC were found on the vascular endothelium in 58%, 53% and 79% respectively. In all biopsies there was an upregulation of both HLA-I and HLA-DR. Proinflammatory cytokines and TNFalphaR75 were also produced locally (IL-1beta in 71%, IFN-gamma in 40%, IL-12 in 73%, TNFalphaR75 in 90%). The anti-inflammatory cytokine IL-10 was simultaneously expressed in 96% of the biopsies. HLA-DR, TNFalphaR75 and IL-10 differed significantly when compared with control muscle biopsies. Our data provide evidence that small numbers of activated leukocytes producing both pro- and anti-inflammatory cytokines infiltrate skeletal muscle of CIPNM patients. We propose that the local balance of leukocyte activities is of importance in the pathophysiology of muscle weakness in CIPNM.


Subject(s)
Critical Illness , Cytokines/physiology , Immune System/physiopathology , Muscles/immunology , Muscles/metabolism , Muscular Diseases/immunology , Polyneuropathies/immunology , Antigens, CD/metabolism , HLA-DR Antigens/metabolism , Humans , Immunohistochemistry , Incidence , Intercellular Adhesion Molecule-1/metabolism , Interleukin-10/metabolism , Longitudinal Studies , Muscles/pathology , Muscular Diseases/epidemiology , Muscular Diseases/metabolism , Muscular Diseases/pathology , Netherlands , Polyneuropathies/epidemiology , Polyneuropathies/metabolism , Polyneuropathies/pathology , Prospective Studies , Receptors, Tumor Necrosis Factor/metabolism , Receptors, Tumor Necrosis Factor, Type II
6.
Eur Cytokine Netw ; 10(4): 471-8, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10586113

ABSTRACT

The inflammatory myopathies (IM), dermatomyositis (DM), polymyositis (PM) and idiopathic inclusion body myositis (IBM) are acquired immune-mediated myopathies. About their pathogenesis and etiology no definitive insights are available yet. Here we present a review of cytokine studies in IM. Combined with cellular immunohistochemical findings a model is presented describing a common mechanism of immune activation in IM. This model is based on a "hit" triggering local cytokine production with dominance of pro-inflammatory cytokines, like IFN-gamma and Th1-mediated activities. The altered Th1-Th2 balance necessitates detection of the anti-inflammatory arm of immune activation, which includes Th2-derived IL-4, IL-1, and Th3/Tr1 derived IL-10 and TGF-beta. Redirection of the ratio provides targets for novel immunotherapy by direct inhibition of the IFN-gamma-mediated Th1 response, stimulation of Th3/Tr1, or IL-4-secreting Th2-cells, negative feedback inhibition with IFN-beta and IFN-gamma and inactivation of MHC molecules.


Subject(s)
Cytokines/immunology , Muscle, Skeletal/immunology , Muscle, Skeletal/pathology , Myositis/immunology , Humans , Immunosuppressive Agents/therapeutic use , Immunotherapy , Lymphocyte Activation/immunology , Models, Immunological , Myositis/pathology , Myositis/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...